Аннотации:
Breast cancer is the second most common cancer in the world and the most common cancer among women. However, in addition to high morbidity and mortality, there is a problem of a slightly different plan – ovarian toxicity of chemotherapeutic agents and the associated chemo-induced premature ovarian failure. Results of the examine of the characteristics of the reproductive health of women after chemotherapy for malignant neoplasms of the breast are presented in this article. It was shown that in the contingent of women suffering from malignant neoplasms of the breast, the share of women of reproductive age is 24.70%, and chemotherapy, as part of comprehensive treatment, receive 19.90% of women. The frequency of menstrual disorders during the first year after chemotherapy is 68.75%, and after 2 years increases to 78.13%.